Medical equipment into the golden age of the field |

Pharmaceutical Network January 31 hearing under the guidance of the concept of value investment, more and more investment value this year oversold plate gain market attention, and this phenomenon in the overall market this week, the context of the overall adjustment is particularly prominent.Among them, The shares of the medical device sector, which are generally at a low level in the concept stocks, hit a downtrend yesterday. According to statistics, the sector rose as much as 0.42% yesterday, with Tianhua Net (3.76%), Tiger Medical (3.61%), 3.0%) and other stocks more prominent performance, yesterday rose more than 3%.

News surface, recently, by the state food drug Regulatory Administration Organization developed the "medical equipment standard Planning (2018-2020) "(referred to as the 'Planning') was formally issued, the plan not only put forward 'By 2020, the basic medical equipment to meet the regulatory needs of medical equipment standard system', 'medical device standardization of international cooperation and exchange more in-depth , The international influence and the gradual improvement of the right to speak, "and other overall goals, but also pointed out that 'standardize the standard management, effectively improve the quality of medical equipment standards' and other six major tasks. In this regard, the industry said that the policy side of the force is expected to Enhance our medical equipment enterprise Of the international influence and accelerate the import substitution process of domestic medical devices, helping our country into the golden age in the field of medical devices.

Benefit from the growth in demand and policy support, the medical device industry as a whole to maintain rapid performance growth.Securities Daily Market Research Center According to statistics found that as of yesterday, the two cities a total of 57 medical device listed companies have disclosed 2017 Annual report performance notice, of which 47 companies pre-hi performance, accounting for more than Bacheng which, BOE A, Star General Medical, Tiger medicine In addition, * ST Jianfeng, GF, Chitianhua and other companies are also expected to achieve year-on-year losses during the reporting period.

According to the statistics, since May 11, 2017, there have been a total of 47 stocks in the sector, which have been falling in total. Compared with the same period, the Shanghai Composite Index In fact, as of yesterday, there are still some blue chips in the blue chip stocks in the bottom range since 2017, based on the latest closing price and the lowest since 2017 (before the right to restore) calculation, the third The latest closing prices of 8 individual stocks of Xin Medical, Kyushu Tong, Shangrong Medical, Cheng Yi Tong, Dean Diagnostics, Jia Shi Tang, Lu Yan Medicine and Bo Hui Innovation rose only less than 5% from the lowest level since 2017. In addition, Shares of Kehua Bio, Zhongyuan, Ruikang, Changzhou Aluminum, Huangshan Capsule, Tianhua Super Clean, Boshi, Jinhua and other stocks closed at the lowest price since 2017, but the cumulative increase is less than 10%.

It is noteworthy that, as the market value of this year continued to increase ability to explore, the above medical instruments In particular, Diane Diagnostics, Tianhua Super Clean, Sanxin Medical, Zhongyuan, Kyushu, Ruikang, Bohui Innovations and other seven stocks At the bottom of the blue chip stocks in the past 5 days the average daily turnover of the average daily turnover over the year showed a significant increase of more than 10%, while analysts also said that with the gradual active trading, in the bottom of the merit-based bid is most likely to Short-term performance, it is worth close attention.